Teena Ferguson

Programme Director, Genomic Medicine, North West London
Teena has been working for the Trust since 2014 and is responsible for developing the strategic vision and genomic medicine strategy for northwest London. Teena has spent the last seven years delivering NHS England’s 100,000 Genomes Project for West London, taking it from a research pilot into a commissioned service in routine healthcare and this has included embedding the national vision of genomic medicine into mainstream operational medicine by consolidating existing services such as genetic testing and sample taking, creating joint clinics and multi-disciplinary genomic tumour advisory boards (GTABs), and providing community education and awareness campaigns to overcome the publics negative perception of whole genome sequencing and data sharing.

Demetra Georgiou

Genomic Transformation Manager, North West London
Demetra has been working at the Trust since 2019 and is responsible for embedding the newly commissioned NHS genomic medicine service into business as usual across northwest London. She is interested in using digital tools to help improve patient and clinician experience. During her time at the Trust Demetra has been seconded to the North Thames Genomic Medicine Service Alliance (GMSA) one day a week to advice on education and awareness campaigns and is currently the Vice Chair of the British Society of Genomic Medicine.

 Patrizia Viola

Genomic Clinical Lead (Pathology), North West London Pathology
Patrizia has been working for the Trust since 2016 as consultant histopathologist with special interest in thoracic pathology, gynaecology pathology and cytopathology.  Through the years Patrizia has developed an interest in molecular pathology and genomic medicine and was awarded an MSc in cancer, molecular pathology and genomics from Queen Mary University, London in 2021.

She has translated this interest in research projects focusing to raise awareness on the importance of molecular testing/ genomic medicine to address personalised treatments especially in lung cancer.

As genomic clinical lead for pathology she is looking on how to improve WGS testing pathways/service for solid tumour as well as streamline test orders/results/tracking across NW London.

Kehinde (Kenny) Fakayode

Genomics Practitioner, North West London
Kenny has been working at the Trust since 2017 and is responsible for working collaboratively with clinicians and external multi-disciplinary teams to embed genomic medicine into business as usual. In her role, Kenny also supports regional clinics with WGS consenting, sample tracking, reconsent for children who participated in the 100,000 genomes projects, and responding to patient queries. During her time at the Trust, Kenny has completed her MSc in Biomedical Science.

Emanuel (Manu) Curetean

Genomics Practitioner
Emanuel has been working at the Trust since 2018 and is responsible for supporting departments, clinicians and patients, with any questions they may have to help embed genomic medicine testing across the Trust.  Emanuel is an expert in all things data and often finds himself responsible for providing technical troubleshooting, and logistical support, to the users of the many systems we use for this new service, and has led on several data management and analysis projects.

Jennifer (Jenny) Pascual

Genomics Practitioner
Jenny is a trained nurse and has been working at the Trust since 2018 .  In her role, Jenny is responsible for setting up new WGS clinics and drafting the supporting policies and operating procedures to support them.  Jenny has been successful in the mainstreaming of several WGS clinics such as adult and paediatric neurogenetic  and haematology clinics and works closely with the regional genetic team based at Northwick Park Hospital.

Claire Shovlin

Professor of Practice (Clinical and Molecular Medicine), Imperial College London

Genomics Lead (Community), North West London
Claire has been a Hammersmith-based Respiratory Consultant since 1999, delivering general, respiratory and specialty medical care at ICHT. For 30 years, Claire has also integrated genomics research with clinical questions and public-professional genomics education, holding multiple national and local Genomics Leadership roles including in set-up and delivery of the 100,000 Genomes Project for ICHT, the MSc in Genomic Medicine for Imperial College, and co-leading the Imperial BRC theme on Social, Genetic and Environmental Determinants of Health. Most recently, her seven 2023 Genomics research papers address new types and consequences of genomic variation; help explain why people differ in their diseases and drug responses, and are establishing robust genomic frameworks for clinical trials to improve health. For more detail, please see www.imperial.ac.uk/people/c.shovlin. 

Ashish (Ash) Sinha

Genomic Clinical Lead (Cancer), North West London

Mr Sinha is a Consultant Colorectal Surgeon at St Mark's, The National Bowel Hospital. He is the surgeon to the St Mark's Centre for Familial Intestinal Cancers. He has a specialist interest in the management of patients with inherited colorectal cancer and polyposis syndromes alongside gastrointestinal cancers. He is a member of the newly established 'rare diseases collaborative network (RDCN)' - the national polyposis multidisciplinary team. 

His research into the surgical management of familial adenomatous polyposis (FAP) and studies into rare desmoid tumours culminated in him being awarded a MD (Research) degree from Imperial College. He is an honorary Clinical Senior Lecturer at Imperial College, Faculty of Medicine, Department of Surgery and Cancer. He is a keen advocate for embedding genomics into multidisciplinary cancer meetings.

Fleur van Dijk 

Genomic Clinical Lead (Rare Disease), North West London

Fleur van Dijk is an experienced consultant clinical geneticist and has been working in Northwest Thames Regional Genetics Service (NWTRGS) covering Northwest London (NWL) since 2016. She also runs a separate nationally commissioned highly specialised service since 2016. Since 2017 she is Genetics lead of NWL Clinical Research Network. She has received NIHR funding to set up the NEEDS research study and contributes towards setting up of other genetic studies in NWL, several of these in collaboration with the section of genomics and genetics in Imperial College. She has a passion for clinical and translational research especially in the field of inherited connective tissue disorders as her publications show. Currently, diagnostic and therapeutic possibilities for rare genetic disease are increasing. As part of her role as Genomic Clinical co-Lead, Rare Disease in NWL she aims to improve access for patients in NWL to these possibilities.

 Virgina Clowes

Genomic Clinical Lead (Rare Disease), North West London